STOCK TITAN
  1. Home
  2. CNCE

Concert Pharm Stock Price, News & Analysis

CNCE NASDAQ

Company Description

Concert Pharm (NASDAQ: CNCE) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

CNCE stock has gained 201.1% over the past year.

This page provides a comprehensive overview of CNCE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+201.08%
Performance 1 year
$0.0
Market Cap
47.9M
Shares outstanding

Concert Pharm (CNCE) stock. Over the past 12 months, the stock has gained 201.1%.

Latest News

View All
+0.12%

Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata

fda approval
+20.14%

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

acquisition
-1.57%

Concert Pharmaceuticals to Participate in Fireside Chat at the Jefferies London Healthcare Conference

conferences
-20.11%

Concert Pharmaceuticals Reports Third Quarter 2022 Financial Results

earnings
-1.33%

Concert Pharmaceuticals to Report Third Quarter 2022 Results on November 7, 2022

conferences earnings
+0.15%

Concert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 Phase 3 Data in Alopecia Areata During Late Breaking Session at EADV Congress

clinical trial

Concert Pharm has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include fda approval, acquisition, conferences, earnings, clinical trial. View all CNCE news →

SEC Filings

View All

No SEC filings available for CNCE.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CNCE Company Profile & Sector Positioning

Concert Pharm (CNCE) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.